Merck & Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

MRK
Merck &

Last Price:

117.15

Seasonality Move:

4.08%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Merck & Price Quote

$117.15

-0.08 (-0.07%)

(Updated: September 20, 2024 at 6:55 PM ET)

Merck & Key Stats

Sell

Merck & (MRK) is a Sell

Day range:

$116.41 - $117.50

52-week range:

$99.14 - $134.63

Dividend yield:

2.63%

P/E ratio:

837.36

P/S ratio:

4.77

P/B ratio:

6.82%

Volume:

9.6M

Avg. volume:

8.4M

1-year change:

9.19%

Market cap:

$297.2B

Revenue:

$60.1B

EPS:

$5.39

How Much Does Merck & Make?

How Much Are Merck &'s Sales Annually?
MRK Revenues are $60.1B
How Much Profit Does Merck &'s Make A Year?
MRK net income is $365M

Is Merck & Growing As A Company?

What Is Merck &'s Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07%
What Is Merck &'s EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Merck & Stock Price Performance

Did Merck & Stock Go Up Last Month?
Merck & share price went up by 2.46% last month
Did MRK's Share Price Rise Over The Last Year?
MRK share price rose by 9.19% over the past 1 year

What Is Merck & 52-Week High & Low?

What Is Merck &’s 52-Week High Share Price?
Merck & has traded as high as $134.63 over the past 52 weeks
What Is Merck &’s 52-Week Low Share Price?
Merck & has traded as low as $99.14 over the past 52 weeks

Merck & Price To Free Cash Flow

Is Merck & Stock Overvalued?
Merck & is trading at a price to free cash flow ratio of 22.68
Is Merck & Stock Undervalued?
Merck & EV to Free Cash Flow ratio is 24.62
What Is Merck &’s Price Earnings Growth Ratio?
MRK PEG ratio is 0.06
Is Merck & Trading At A Premium To Earnings?
Merck & EV to EBIT ratio is 19.63

Is It Risky To Buy Merck &?

How Much Debt Does Merck & Have?
Total long term debt quarterly is $37.8B
How Much Cash Does Merck & Have?
Cash and short term investments quarterly total is $11.4B
What Is Merck &’s Book Value Per Share?
Book value per share is 17.19

Is Merck & Cash Flow Positive?

What Is MRK Cash Flow From Operations?
Cash flow from operations (TTM) is $16.7B
What Is Merck &’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$8.1B
What Is Merck &’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.7B

Merck & Return On Invested Capital

Is Management Doing A Good Job?
MRK return on invested capital is 18.05%
What Is Merck & Return On Assets?
ROA measures how assets are converting to revenues and is 12.81%
What Is MRK Return On Equity?
ROE is a measure of profitability and is 34.04%

Merck & Earnings Date & Stock Price

What Is Merck &'s Stock Price Today?
A single share of MRK can be purchased today for 117.23
What Is Merck &’s Stock Symbol?
Merck & trades on the S&P500 under the ticker symbol: MRK
When Is Merck &’s Next Earnings Date?
The next quarterly earnings date for Merck & is scheduled on October 25, 2024
When Is MRK's next ex-dividend date?
Merck &'s next ex-dividend date is September 16, 2024
How To Buy Merck & Stock?
You can buy Merck & shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Merck & Competitors

Who Are Merck &'s Competitors?
Below is a list of companies who compete with Merck & or are related in some way:
- Amgen Inc (AMGN)
- Johnson & Johnson (JNJ)
- Eli Lilly and Co (LLY)
- Moderna Inc (MRNA)
- Pfizer Inc (PFE)

Merck & Dividend Yield

What Is MRK Dividend Yield?
Merck &’s dividend yield currently is 2.63%
What Is Merck &’s Payout Ratio?
Merck &’s payout ratio is 55.64%
When Did Merck & Last Pay A Dividend?
The latest dividend pay date is September 21, 2024
What Is Merck &’s Dividend Per Share?
Merck & pays a dividend of $0.77 per share

Merck & Analyst Estimates

	YoY Growth	Past Surprise
EPS:	0%	6.31%
Revenue:	7.16%	1.69%

Analyst Recommendations

Buy Recommendations:	18
Hold Recommendations:	4
Sell Recommendations:	0
Price Target:	139.03
Upside from Last Price:	18.59%

Major Shareholders

How many MRK shares are owned by institutional investors?
3.1B MRK shares are owned by institutional investors
How many MRK shares are owned by insiders?
3.8M MRK shares are owned by insiders